Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma - Top-Institutions - MDSpire

Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma

  • By

  • Lara C. Avsharian

  • Suvithanandhini Loganathan

  • Nancy D. Ebelt

  • Rebecca E. Ruggiero-Ruff

  • Sheyla Salcido

  • Skye E. Inal

  • Meera G. Nair

  • Edwin R. Manuel

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, MO

    Key Differentiators

    • Oncology

  • #2

    City of Hope Biomedical Research Center
    City of Hope Biomedical Research Center

    Duarte, CA

    Key Differentiators

    • Oncology

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #5

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology

Original Source(s)

Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma

  • by Lara C. Avsharian, Suvithanandhini Loganathan, Nancy D. Ebelt, Rebecca E. Ruggiero-Ruff, Sheyla Salcido, Skye E. Inal, Meera G. Nair, Edwin R. Manuel

  • July 15, 2026

Related Content

Circular RNA circEVI5 functions as a miR-433 sponge to promote renal cell carcinoma progression via GBP2-mediated oncogenic signaling

Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer

Ten reasons why acute respiratory failure is different in the immunocompromised host